Purple Biotech (Israel) Market Value
| KTOV Stock | ILA 5.10 0.10 2.00% |
| Symbol | Purple |
Purple Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Purple Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Purple Biotech.
| 12/15/2024 |
| 03/15/2025 |
If you would invest 0.00 in Purple Biotech on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding Purple Biotech or generate 0.0% return on investment in Purple Biotech over 90 days. Purple Biotech is related to or competes with Azorim Investment, Golan Plastic, Isras Investment, Ram On, Analyst IMS, and Feat Fund. Kitov Pharma Ltd, a clinical-stage pharmaceutical company, focuses on the development and commercialization of various p... More
Purple Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Purple Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Purple Biotech upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.23 | |||
| Information Ratio | 0.0641 | |||
| Maximum Drawdown | 105.74 | |||
| Value At Risk | (10.00) | |||
| Potential Upside | 12.77 |
Purple Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Purple Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Purple Biotech's standard deviation. In reality, there are many statistical measures that can use Purple Biotech historical prices to predict the future Purple Biotech's volatility.| Risk Adjusted Performance | 0.0585 | |||
| Jensen Alpha | 0.1011 | |||
| Total Risk Alpha | 2.37 | |||
| Sortino Ratio | 0.1349 | |||
| Treynor Ratio | (0.13) |
Purple Biotech Backtested Returns
Purple Biotech maintains Sharpe Ratio (i.e., Efficiency) of -0.13, which implies the firm had a -0.13 % return per unit of risk over the last 3 months. Purple Biotech exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Purple Biotech's Risk Adjusted Performance of 0.0585, semi deviation of 5.67, and Coefficient Of Variation of 1769.16 to confirm the risk estimate we provide. The company holds a Beta of -5.78, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Purple Biotech are expected to decrease by larger amounts. On the other hand, during market turmoil, Purple Biotech is expected to outperform it. At this point, Purple Biotech has a negative expected return of -0.55%. Please make sure to check Purple Biotech's total risk alpha, treynor ratio, value at risk, as well as the relationship between the sortino ratio and maximum drawdown , to decide if Purple Biotech performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.59 |
Modest predictability
Purple Biotech has modest predictability. Overlapping area represents the amount of predictability between Purple Biotech time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Purple Biotech price movement. The serial correlation of 0.59 indicates that roughly 59.0% of current Purple Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.59 | |
| Spearman Rank Test | 0.36 | |
| Residual Average | 0.0 | |
| Price Variance | 0.13 |
Purple Biotech lagged returns against current returns
Autocorrelation, which is Purple Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Purple Biotech's stock expected returns. We can calculate the autocorrelation of Purple Biotech returns to help us make a trade decision. For example, suppose you find that Purple Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Purple Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Purple Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Purple Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Purple Biotech stock over time.
Current vs Lagged Prices |
| Timeline |
Purple Biotech Lagged Returns
When evaluating Purple Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Purple Biotech stock have on its future price. Purple Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Purple Biotech autocorrelation shows the relationship between Purple Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in Purple Biotech.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Purple Stock
When determining whether Purple Biotech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Purple Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Purple Biotech Stock. Highlighted below are key reports to facilitate an investment decision about Purple Biotech Stock:Check out Purple Biotech Correlation, Purple Biotech Volatility and Purple Biotech Alpha and Beta module to complement your research on Purple Biotech. For information on how to trade Purple Stock refer to our How to Trade Purple Stock guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Purple Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.